NEXT GENERATION STROKE TECHNOLOGY

Perfuze is developing innovative medical technology for clot removal in stroke patients

INNOVATION

Scroll to Explore

References

(1) World Stroke Organisation www.world-stroke.org 2020
(2) Mozaffarian et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association. Circulation 2015

ABOUT ISCHEMIC STROKE

Stroke is the second leading cause of death and is the leading cause of adult disability. 1,2
Over 13 million people worldwide will have a stroke this year and more than 5 million people will die as a result. 1,2
Learn More

RESEARCH

References

(3) Nogueira et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N. Engl. J. Med. 2016
(4) Goyal et al. Endovascular Thrombectomy after Large-Vessel Ischaemic Stroke: A Meta-Analysis of Individual Patient Data from Five Randomised Trials. The Lancet 2016

UNMET CLINICAL NEED

Despite recent clinical advances in stroke therapy, less than 50% of stroke patients treated today achieve a positive clinical outcome. 3,4
Learn More

TECHNOLOGY

Video Button Icon Watch Full Video

THE SOLUTION

Learn More

OUR COMPANY

Perfuze was founded in 2018 by Wayne Allen and Liam Mullins and are located in Galway City in the West of Ireland.
The Team Careers

Knowledge